| Ambetter Health Texas Superior Marketplace Clinical | Eluxadoline | 2025-11-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Enasidenib | 2025-11-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Entrectinib | 2025-11-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Eptinezumab-jjmr | 2025-11-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Erenumab-aooe | 2025-11-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Eribulin Mesylate | 2025-11-01 |
| Ambetter Health Texas Superior Medicaid Clinical | No Coverage Criteria, Recent Label Changes Pending | 2025-11-01 |
| Ambetter Health Texas Superior Medicaid Clinical | Obinutuzumab | 2025-11-01 |
| Ambetter Health Texas Superior Medicaid Clinical | Off-Label Use | 2025-11-01 |
| Ambetter Health Texas Superior Medicaid Clinical | Palopegteriparatide | 2025-11-01 |